Claudin 1 Plays Crucial Role in Regulating Tumor Necrosis Factor-Alpha-induced Gene Expression in Gastric Cancer Cells
Research conducted at the University of Toronto has shed light on the role of claudin 1 in regulating genes involved in cell migration and tumor necrosis factor-alpha (TNF-alpha)-induced gene expression in human gastric adenocarcinoma cells. The study, published in the World Journal of Gastroenterology, found that the knockdown of claudin 1 significantly inhibited cell proliferation, migration, and invasion, and increased apoptosis in MKN28 cells.
Key Takeaways:
- The knockdown of claudin 1 significantly inhibited cell proliferation, migration, and invasion, and increased apoptosis in MKN28 cells.
- Claudin 1 is an important messenger that regulates TNF-alpha-induced gene expression and migration in gastric cancer cells.
- Microarray analysis identified 245 genes whose expression levels were altered by the knockdown of claudin 1.
- The top-ranked molecular and cellular function affected by claudin 1 knockdown was the cellular movement-related pathway.
- TNF-alpha treatment increased claudin 1 expression and cell migration in MKN28 cells.
- The depletion of claudin 1 inhibited 80% of the TNF-alpha-induced mRNA expression changes.
- Claudin 1 siRNA transfected cells did not enhance cell migration in response to TNF-alpha treatment.
- The results suggest that a deeper understanding of these cellular processes may be helpful in establishing new therapeutic strategies for gastric cancer.
Statistics:
- 245 genes were identified as having altered expression levels in response to claudin 1 knockdown.
- 80% of TNF-alpha-induced mRNA expression changes were inhibited by the depletion of claudin 1.
- 2014: the year the research was published in the World Journal of Gastroentrology.
- The study involved the analysis of gene expression profiles from human gastric adenocarcinoma cells using microarray and bioinformatics tools.
Sources:
- World Journal of Gastroenterology (2014); 20(47): 17863-17876.
- Baishideng Publishing Group Inc, 8226 Regency Dr, Pleasanton, CA 94588, USA.
- A. Shiozaki, University of Toronto, Fac Med, Dept. of Surg, Toronto, ON M5G 1L7, Canada.